Increase in serum osmolality is possible mechanism for the beneficial effects of glycerol in childhood bacterial meningitis

Pediatric Infectious Disease Journal

Volumn 27, Issue 10, 2008, Pages 892-896

  Singhi, Sunit ^a   Järvinen, Asko ^b   Peltola, Heikki ^b,c  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Adjunctive treatment therapy; Dexamethasone; Glycerol; Meningitis

Indexed keywords

CEFTRIAXONE; DEXAMETHASONE; GLYCEROL; PLACEBO;

ABSENCE OF SIDE EFFECTS; ADJUVANT THERAPY; ARTICLE; BACTERIAL MENINGITIS; BLOOD PRESSURE; BRAIN BLOOD FLOW; CEREBROSPINAL FLUID; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FOLLOW UP; GLASGOW COMA SCALE; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; INFANT; INTRACRANIAL HYPERTENSION; IRRITABILITY; MUSCLE RIGIDITY; NEUROLOGICAL COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEIZURE; SERUM OSMOLALITY; STAPHYLOCOCCUS AUREUS; STIFF NECK; STREPTOCOCCUS PNEUMONIAE; URINE VOLUME; BLOOD; BRAIN CIRCULATION; FEMALE; MALE; MICROBIOLOGY; OSMOLARITY; PRESCHOOL CHILD; STAPHYLOCOCCUS INFECTION;

CEFTRIAXONE; CEREBROVASCULAR CIRCULATION; CHILD; CHILD, PRESCHOOL; DEXAMETHASONE; DOUBLE-BLIND METHOD; FEMALE; GLYCEROL; HUMANS; INFANT; MALE; MENINGITIS, BACTERIAL; MENINGITIS, HAEMOPHILUS; MENINGITIS, PNEUMOCOCCAL; OSMOLAR CONCENTRATION; STAPHYLOCOCCAL INFECTIONS;

EID: 54049109721     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318175d177     Document Type: Article

References (42)

1. Swartz MN. Bacterial meningitis-a view of the past 90 years. New Engl J Med. 2004;351:1826-1828.
2. Peltola H, Anttila M, Renkonen OV. Randomised comparison of chlor- amphenicol, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis. The Finnish Study Group. Lancet. 1989;1:1281-1287.
3. Daoud AS, Al-Sheyyab M, Batchoun RG, Rawashdeh MO, Nussair MM, Pugh RN. Bacterial meningitis: still a cause of high mortality and severe neurological morbidity in childhood. J Trop Pediatr. 1995;41: 308-310.
4. Goetghebuer T, West TE, Wermenbol V, et al. Outcome of meningitis caused by Streptococcus pneumoniae and Haemophilus influenzae type b in children in The Gambia. Trop Med Int Health. 2000;5:207-213.
5. Peltola H. Burden of meningitis and other severe bacterial infections of children in Africa: implications for prevention. Clin Infect Dis. 2001; 32:64-75.
6. Duke T, Mokela D, Frank D, et al. Management of meningitis in children with oral fluid restriction or intravenous fluid at maintenance volumes: a randomized trial. Ann Trop Paediatr. 2002;22:145-157.
7. Grimwood K, Anderson P, Anderson V, Tan L, Nolan T. Twelve year outcomes following bacterial meningitis: further evidence for persisting effects. Arch Dis Child. 2000;83:111-116.
8. Khan NZ, Kalter H, Hanif M, Schilllinger J, Saha SK, Black RE. Meningitis treatment without follow-up: what are we missing? Lancet. 1995;346:706.
9. Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev. 2000;13:302-317.
10. Sierra-Fernandez H, Schultz-Faingezicht M, Soley-Gutiérrez C, Guevara-Jiménez S, Arguedas-Mohs A. Estado actual de la vacuna conjugada contra Streptococcus pneumoniae. Acta Med Costar. 2006; 48:66-71.
11. Mustafa MM, Ramilo O, Mertsola J, et al. Modulation of inflammation and cachectin activity in relation to treatment of experimental Haemophilus influenzae type b meningitis. J Infect Dis. 1989;160:818-825.
12. Lebel MH, Freij BJ, Syrogiannopoulos GA, et al. Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo- controlled trials. N Engl J Med. 1988;319:964-971.
13. Odio CM, Faingezicht I, Paris M, et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med. 1991;324:1525-1531.
14. Schaad UB, Lips U, Gnehm HE, Blumberg A, Wedgwood J, Heinzer I. Dexamethasone therapy for bacterial meningitis in children. The Swiss Meningitis Study Group. Lancet. 1993;342:457-461.
15. Wald ER, Kaplan S, Mason EO Jr, et al. Dexamethasone therapy for bacterial meningitis in children. Pediatrics. 1995;95:21-28.
16. Qazi SA, Khan MA, Mughal N, et al. Dexamethasone and bacterial meningitis in Pakistan. Arch Dis Child. 1996;75:482-488.
17. Molyneux EM, Walsh AL, Forsyth H, et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet. 2002;360:211-218.
18. Peltola H, Roine I, Fernandez J, et al. Adjuvant glycerol and/or dexa- methasone to improve toe outcomes of the childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2007;45:1277-1286.
19. van de Beek D, de Gans J, McIntyre P, Prasad K. Corticosteroids in acute bacterial meningitis. Cochrane Database Syst Rev. 2007;1: CD004405.
20. Roine I, Peltola H, Fernandez J, et al. Influence of admission findings on death and neurological outcome from childhood bacterial meningitis. Clin Infect Dis. 2008;46:1248-1252.
21. Kilpi T, Peltola H, Kallio MK, et al. Oral glycerol versus intravenous dexamethasone in preventing hearing impairment due to childhood bacterial meningitis. Pediatr Infect Dis J. 1995;14:270-278.
22. Cantore GP, Guidetti B, Virno M. Oral glycerol for the reduction of intracranial pressure. J Neurosurg. 1964;21:278-283.
23. Buckell M, Walsh L. Effect of glycerol by mouth on raised intracranial pressure in man. Lancet. 1964;2:1151-1152.
24. Menger JS, Charney JZ, Rivera VM, Mathew NT. Treatment with glycerol of cerebral oedema due to acute cerebral infarction. Lancet. 1971;2:993-997.
25. Gilsanz V, Rebollar JL, Buencuerpo J, Chantres MT. Controlled trial of glycerol versus dexamethasone in the treatment of cerebral oedema in acute cerebral infarction. Lancet. 1975;1:1049-1051.
26. Rottenberg DA, Hurwitz BJ, Posner JB. The effect of oral glycerol on intraventricular pressure in man. Neurology. 1977;27:600-608.
27. MacDonald JT, Uden DL. Intravenous glycerol and mannitol therapy in children with intracranial hypertension. Neurology. 1982;32:437-440.
28. Bayer AJ, Pathy MSJ, Newcombe R. Double-blind randomised trial of intravenous glycerol in acute stroke. Lancet. 1987;1:405-408.
29. Klockhoff I, Lindblom U. Glycerol test in Ménière's disease. Acta Otolaryngol. 1967;(Suppl 224):449-451.
30. Snyder JM. Extensive use of a diagnostic test for Ménière's disease. Arch Otolaryngol. 1974;100:3360-3365.
31. McCurdy DK, Schneider B, Scheie HG. Oral glycerol: the mechanism of intraocular hypotension. Am J Ophthalmol. 1966;61:1244-1249.
32. Singhi SC, Singhi PD, Srinivas B, et al. Fluid restriction does not improve the outcome of acute meningitis. Pediatr Infect Dis J. 1995; 14:495-503.
33. Sankar J, Singhi P, Bansal A, Ray P, Singhi S. Role of dexamethasone and oral glycerol in reducing hearing and neurological sequelae in children with bacterial meningitis. Indian Pediatr. 2007;44:649-656.
34. Ashwal S, Stringer W, Tornasi L, Schneider S, Thompson J, Perkin R. Cerebral blood flow and carbon dioxide reactivity in children with bacterial meningitis. J Pediatr. 1990;117:523-530.
35. Leib SL, Tauber MG. Pathogenesis of bacterial meningitis. Infect Dis Clin North Am. 1999;13(Suppl 3):527-548.
36. Nathan BR, Scheld WM. New advances in the pathogenesis and pathophys- iology of bacterial meningitis. Curr Infect Dis Rep. 2000;2:332-336.
37. Sáez-Llorens X, McCracken G Jr. Bacterial meningitis in children. Lancet. 2003;361:2139-2148.
38. Hurley JC. Antibiotic-induced release of endotoxin: a reappraisal. Clin Infect Dis. 1992;15:840-854.
39. Zoghbi HV, Okumura S, Fishman MA. Acute effect of glycerol on net CSF production in dogs. Neurosurgery. 1985;63:756-762.
40. Tibbling G. Glycerol turnover in hyperthyroidism. Clin Chim Acta. 1969;24:121-130.
41. Nau R, Prins FJ, Kolenda H, Prange HW. Temporary reversal of serum to cerebrospinal fluid glycerol concentration gradient after intravenous infusion of glycerol. Eur J Clin Pharmacol. 1992;42:181-185.
42. Sommer S, Nau R, Wieland E, Prange HW. Pharmacokinetics of glycerol administered orally in healthy volunteers. Arzneimittelfors-chung. 1993;43:744-747.